Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation | Zendy

Mohammed Nazmul | Zendy; YongMei Cha | Zendy; Grace Lin | Zendy; Samuel J. Asirvatham | Zendy; Brian D. Powell | Zendy

Open Access

Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation

Author(s) -

Mohammed Nazmul,

YongMei Cha,

Grace Lin,

Samuel J. Asirvatham,

Brian D. Powell

Publication year - 2012

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eus342

Subject(s) - medicine , percutaneous , implantable cardioverter defibrillator , regurgitation (circulation) , cardiology , lead (geology) , geomorphology , geology

Pacemaker and implantable cardioverter-defibrillator (ICD) leads can cause tricuspid valve regurgitation (TR). Few data are available on the best management of significant TR that develops after pacemaker or ICD implantation and regarding any benefits of right ventricular (RV) lead extraction. We sought to determine the impact of RV lead removal on lead-induced TR.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research